Position in BDTX
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$228,762
-$90,632 QoQ
Shares Held
107,400
-18.3% QoQ
Ownership
0.187%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
9 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in BDTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Invesco Ltd. holds $8,194,153,126 across 259 Biotechnology names. BDTX ranks #210 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,724,478 | $1,332,400,669 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,561,057 | $1,143,614,384 | |
| 3 | ARGX |
Argenx SE
|
594,697 | $434,277,482 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,291,726 | $427,393,371 | |
| 5 | INCY |
Incyte Corp
|
3,870,764 | $364,316,298 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
|
4,592,814 | $341,062,362 | |
| 7 | INSM |
INSMED Inc
|
1,988,968 | $325,236,040 | |
| 8 | HALO |
Halozyme Therapeutics, Inc.
|
4,012,494 | $259,327,483 |
All Filings in BDTX
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $228,762 | 107,400 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $319,394 | 131,438 | Shares | Defined | 2026-02-19 | |
| 2025-09-30 | $361,353 | 95,344 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $149,320 | 60,210 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $71,282 | 45,989 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $38,972 | 18,212 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $76,036 | 17,480 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $3,319,699 | 712,382 | Shares | Defined | 2024-08-13 | |
| 2021-09-30 | $89,953 | 10,633 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||